Toll Free: 1-888-928-9744

Interventional Neurology - Medical Devices Pipeline Assessment, 2015

Dec 31, 2015 | 192 Pages | GlobalData | Medical Devices

Interventional Neurology - Medical Devices Pipeline Assessment, 2015

Summary

GlobalData's Medical Devices sector report, "Interventional Neurology - Medical Devices Pipeline Assessment, 2015" provides an overview of Interventional Neurology currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Interventional Neurology pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Interventional Neurology under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Interventional Neurology and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to Buy

The report enables you to - 
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Interventional Neurology under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
 Table of Contents

1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 12

2 Introduction 13
2.1 Interventional Neurology Overview 13
3 Products under Development 14
3.1 Interventional Neurology - Pipeline Products by Stage of Development 14
3.2 Interventional Neurology - Pipeline Products by Segment 15
3.3 Interventional Neurology - Pipeline Products by Territory 17
3.4 Interventional Neurology - Pipeline Products by Regulatory Path 18
3.5 Interventional Neurology - Pipeline Products by Estimated Approval Date 19
3.6 Interventional Neurology - Ongoing Clinical Trials 20

4 Interventional Neurology - Pipeline Products under Development by Companies 21
4.1 Interventional Neurology Companies - Pipeline Products by Stage of Development 21
4.2 Interventional Neurology - Pipeline Products by Stage of Development 24

5 Interventional Neurology Companies and Product Overview 27
5.1 Alcyone Lifesciences, Inc. Company Overview 27
5.1.1 Alcyone Lifesciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
5.2 Aneuclose LLC Company Overview 28
5.2.1 Aneuclose LLC Pipeline Products & Ongoing Clinical Trials Overview 28
5.3 Apeliotus Technologies Company Overview 30
5.3.1 Apeliotus Technologies Pipeline Products & Ongoing Clinical Trials Overview 30
5.4 Arterain Medical Inc. Company Overview 31
5.4.1 Arterain Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
5.5 Avantec Vascular Corporation Company Overview 32
5.5.1 Avantec Vascular Corporation Pipeline Products & Ongoing Clinical Trials Overview 32
5.6 Cibiem, Inc. Company Overview 34
5.6.1 Cibiem, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
5.7 Codman & Shurtleff, Inc. Company Overview 37
5.7.1 Codman & Shurtleff, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
5.8 Collagen Matrix, Inc. Company Overview 39
5.8.1 Collagen Matrix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 39
5.9 Cordis Corporation Company Overview 40
5.9.1 Cordis Corporation Pipeline Products & Ongoing Clinical Trials Overview 40
5.10 CranioVation Company Overview 42
5.10.1 CranioVation Pipeline Products & Ongoing Clinical Trials Overview 42
5.11 Dartmouth College Company Overview 43
5.11.1 Dartmouth College Pipeline Products & Ongoing Clinical Trials Overview 43
5.12 DePuy Companies Company Overview 45
5.12.1 DePuy Companies Pipeline Products & Ongoing Clinical Trials Overview 45
5.13 EchoGuide Medical, Inc. Company Overview 55
5.13.1 EchoGuide Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
5.14 EKOS Corporation Company Overview 56
5.14.1 EKOS Corporation Pipeline Products & Ongoing Clinical Trials Overview 56
5.15 Gaudi Vascular, Inc. Company Overview 57
5.15.1 Gaudi Vascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57
5.16 Hansjorg Wyss Institute for Biologically Inspired Engineering Company Overview 59
5.16.1 Hansjorg Wyss Institute for Biologically Inspired Engineering Pipeline Products & Ongoing Clinical Trials Overview 59
5.17 Hibernia Medical Company Overview 61
5.17.1 Hibernia Medical Pipeline Products & Ongoing Clinical Trials Overview 61
5.18 Insera Therapeutics, LLC Company Overview 62
5.18.1 Insera Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 62
5.19 InspireMD, Inc. Company Overview 64
5.19.1 InspireMD, Inc. Pipeline Products & Ongoing Clinical Trials Overview 64
5.20 ITGI Medical Ltd. Company Overview 66
5.20.1 ITGI Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 66
5.21 Lazarus Effect, Inc Company Overview 67
5.21.1 Lazarus Effect, Inc Pipeline Products & Ongoing Clinical Trials Overview 67
5.22 Medikit Co., Ltd. Company Overview 70
5.22.1 Medikit Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 70
5.23 Merlin MD Pte. Ltd. Company Overview 75
5.23.1 Merlin MD Pte. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 75
5.24 Metactive Medical, LLC Company Overview 77
5.24.1 Metactive Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 77
5.25 MicroPort Scientific Corporation Company Overview 78
5.25.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 78
5.26 MicroVention, Inc. Company Overview 82
5.26.1 MicroVention, Inc. Pipeline Products & Ongoing Clinical Trials Overview 82
5.27 MindFrame Inc. (Inactive) Company Overview 84
5.27.1 MindFrame Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 84
5.28 Neuravi Limited Company Overview 85
5.28.1 Neuravi Limited Pipeline Products & Ongoing Clinical Trials Overview 85
5.29 NeuroInterventional Therapeutics, Inc. Company Overview 88
5.29.1 NeuroInterventional Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 88
5.30 NeuroInterventions Company Overview 89
5.30.1 NeuroInterventions Pipeline Products & Ongoing Clinical Trials Overview 89
5.31 NeuroSigma, Inc. Company Overview 90
5.31.1 NeuroSigma, Inc. Pipeline Products & Ongoing Clinical Trials Overview 90
5.32 Neurosyntec LLC. Company Overview 91
5.32.1 Neurosyntec LLC. Pipeline Products & Ongoing Clinical Trials Overview 91
5.33 NexGen Medical Systems, Inc. Company Overview 94
5.33.1 NexGen Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 94
5.34 NSVascular, Inc. Company Overview 95
5.34.1 NSVascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 95
5.35 Palmaz Scientific, Inc. Company Overview 97
5.35.1 Palmaz Scientific, Inc. Pipeline Products & Ongoing Clinical Trials Overview 97
5.36 Penumbra, Inc. Company Overview 98
5.36.1 Penumbra, Inc. Pipeline Products & Ongoing Clinical Trials Overview 98
5.37 Philips Healthcare Company Overview 100
5.37.1 Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview 100
5.38 PhotoThera, Inc. Company Overview 102
5.38.1 PhotoThera, Inc. Pipeline Products & Ongoing Clinical Trials Overview 102
5.39 Pulsar Vascular, Inc. Company Overview 110
5.39.1 Pulsar Vascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 110
5.40 Pulse Therapeutics, Inc. Company Overview 111
5.40.1 Pulse Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 111
5.41 Rapid Medical Company Overview 112
5.41.1 Rapid Medical Pipeline Products & Ongoing Clinical Trials Overview 112
5.42 Reverse Medical Corporation Company Overview 113
5.42.1 Reverse Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 113
5.43 Rontis AG Company Overview 116
5.43.1 Rontis AG Pipeline Products & Ongoing Clinical Trials Overview 116
5.44 Sequent Medical, Inc. Company Overview 117
5.44.1 Sequent Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 117
5.45 Shape Memory Therapeutics, Inc. Company Overview 121
5.45.1 Shape Memory Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 121
5.46 Silk Road Medical, Inc. Company Overview 123
5.46.1 Silk Road Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 123
5.47 Strategic Polymer Sciences, Inc Company Overview 127
5.47.1 Strategic Polymer Sciences, Inc Pipeline Products & Ongoing Clinical Trials Overview 127
5.48 Stryker Corporation Company Overview 128
5.48.1 Stryker Corporation Pipeline Products & Ongoing Clinical Trials Overview 128
5.49 Synaptive Medical Inc. Company Overview 133
5.49.1 Synaptive Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 133
5.50 Terumo Corporation Company Overview 137
5.50.1 Terumo Corporation Pipeline Products & Ongoing Clinical Trials Overview 137
5.51 Triticum Medical Ltd. Company Overview 139
5.51.1 Triticum Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 139
5.52 Twin Star Medical, Inc. Company Overview 140
5.52.1 Twin Star Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 140
5.53 University of California, San Francisco Company Overview 142
5.53.1 University of California, San Francisco Pipeline Products & Ongoing Clinical Trials Overview 142
5.54 University of Oxford Company Overview 144
5.54.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 144
5.55 University of South Florida Company Overview 145
5.55.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 145
5.56 University of Wisconsin Madison Company Overview 147
5.56.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 147
5.57 University of Wolverhampton Company Overview 150
5.57.1 University of Wolverhampton Pipeline Products & Ongoing Clinical Trials Overview 150
5.58 Valor Medical, Inc. Company Overview 151
5.58.1 Valor Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 151
5.59 Vascular Solutions, Inc. Company Overview 152
5.59.1 Vascular Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 152
5.60 Viket Medical Corporation Company Overview 154
5.60.1 Viket Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 154
5.61 Zoll Medical Corporation Company Overview 155
5.61.1 Zoll Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 155

6 Interventional Neurology- Recent Developments 157

7 Appendix 189
7.1 Methodology 189
7.2 About GlobalData 191
7.3 Contact Us 192
7.4 Disclaimer 192
List of Tables
Table 1: Interventional Neurology - Pipeline Products by Stage of Development 14 Table 2: Interventional Neurology - Pipeline Products by Segment 16 Table 3: Interventional Neurology - Pipeline Products by Territory 17 Table 4: Interventional Neurology - Pipeline Products by Regulatory Path 18 Table 5: Interventional Neurology - Pipeline Products by Estimated Approval Date 19 Table 6: Interventional Neurology - Ongoing Clinical Trials 20 Table 7: Interventional Neurology Companies - Pipeline Products by Stage of Development 21 Table 8: Interventional Neurology - Pipeline Products by Stage of Development 24 Table 9: Alcyone Lifesciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27 Table 10: Alcyone Microcatheter - Product Status 27 Table 11: Alcyone Microcatheter - Product Description 27 Table 12: Aneuclose LLC Pipeline Products & Ongoing Clinical Trials Overview 28 Table 13: Aneurysm Occlusion Saddle - Product Status 28 Table 14: Aneurysm Occlusion Saddle - Product Description 28 Table 15: Janjua Aneurysm Net - Product Status 29 Table 16: Janjua Aneurysm Net - Product Description 29 Table 17: Apeliotus Technologies Pipeline Products & Ongoing Clinical Trials Overview 30 Table 18: Polymer Stent for Cerebral Aneurysms - Product Status 30 Table 19: Polymer Stent for Cerebral Aneurysms - Product Description 30 Table 20: Arterain Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 31 Table 21: Catheter Based System - Product Status 31 Table 22: Catheter Based System - Product Description 31 Table 23: Avantec Vascular Corporation Pipeline Products & Ongoing Clinical Trials Overview 32 Table 24: Endovascular Embolization Device - Product Status 32 Table 25: Endovascular Embolization Device - Product Description 32 Table 26: Ischemic Stroke Therapy Device - Product Status 33 Table 27: Ischemic Stroke Therapy Device - Product Description 33 Table 28: Cibiem, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34 Table 29: Carotid Body Modulation - Product Status 34 Table 30: Carotid Body Modulation - Product Description 34 Table 31: Cibiem, Inc. - Ongoing Clinical Trials Overview 35 Table 32: Carotid Body Modulation - Endovascular Carotid Body Ablation in Patients with Treatment- resistant Hypertension: A Safety and Feasibility Study 36 Table 33: Codman & Shurtleff, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37 Table 34: Next Generation REVIVE SE - Product Status 38 Table 35: Next Generation REVIVE SE - Product Description 38 Table 36: Collagen Matrix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 39 Table 37: Collagen-based Coils - Product Status 39 Table 38: Collagen-based Coils - Product Description 39 Table 39: Cordis Corporation Pipeline Products & Ongoing Clinical Trials Overview 40 Table 40: Flow Diverter - Product Status 41 Table 41: Flow Diverter - Product Description 41 Table 42: CranioVation Pipeline Products & Ongoing Clinical Trials Overview 42 Table 43: Brain Aneurysm Clip - Product Status 42 Table 44: Brain Aneurysm Clip - Product Description 42 Table 45: Dartmouth College Pipeline Products & Ongoing Clinical Trials Overview 43 Table 46: Aneurysm Clip Applicator - Product Status 43 Table 47: Aneurysm Clip Applicator - Product Description 43 Table 48: Cerebral Aneurysm Clip - Product Status 44 Table 49: Cerebral Aneurysm Clip - Product Description 44 Table 50: DePuy Companies Pipeline Products & Ongoing Clinical Trials Overview 45 Table 51: Covered Stent - Product Status 46 Table 52: Covered Stent - Product Description 46 Table 53: Liquid Embolic System - Product Status 47 Table 54: Liquid Embolic System - Product Description 47 Table 55: Next Generation Balloon Expandable Stent - Product Status 48 Table 56: Next Generation Balloon Expandable Stent - Product Description 48 Table 57: Occlusion Balloons - Product Status 49 Table 58: Occlusion Balloons - Product Description 49 Table 59: PHAROS Vitesse Stent - Product Status 50 Table 60: PHAROS Vitesse Stent - Product Description 50 Table 61: REVIVE SE - Product Status 51 Table 62: REVIVE SE - Product Description 51 Table 63: Self-Expanding Stent - Product Status 52 Table 64: Self-Expanding Stent - Product Description 52 Table 65: DePuy Companies - Ongoing Clinical Trials Overview 53 Table 66: PHAROS Vitesse Stent - Phase III Study of Pharos Vitesse Neurovascular Stent System Compared to Best Medical Therapy for the Treatment of Ischemic Disease 54 Table 67: EchoGuide Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55 Table 68: Ultrasound Catheter Navigation Device - Product Status 55 Table 69: Ultrasound Catheter Navigation Device - Product Description 55 Table 70: EKOS Corporation Pipeline Products & Ongoing Clinical Trials Overview 56 Table 71: EKOS EkoSonic SV System - Neuro Vasculature - Product Status 56 Table 72: EKOS EkoSonic SV System - Neuro Vasculature - Product Description 56 Table 73: Gaudi Vascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57 Table 74: Intracranial Stent - Product Status 57 Table 75: Intracranial Stent - Product Description 57 Table 76: Zippered Microcatheter - Product Status 58 Table 77: Zippered Microcatheter - Product Description 58 Table 78: Hansjorg Wyss Institute for Biologically Inspired Engineering Pipeline Products & Ongoing Clinical Trials Overview 59 Table 79: Blood Clots Clearing Device - Product Status 60 Table 80: Blood Clots Clearing Device - Product Description 60 Table 81: Hibernia Medical Pipeline Products & Ongoing Clinical Trials Overview 61 Table 82: Hybernia Safety Catheter - Neuroprotection - Product Status 61 Table 83: Hybernia Safety Catheter - Neuroprotection - Product Description 61 Table 84: Insera Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 62 Table 85: SHELTER - Product Status 63 Table 86: SHELTER - Product Description 63 Table 87: InspireMD, Inc. Pipeline Products & Ongoing Clinical Trials Overview 64 Table 88: NVGuard Neurovascular - Product Status 65 Table 89: NVGuard Neurovascular - Product Description 65 Table 90: ITGI Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 66 Table 91: Mechanical Thrombectomy Device - Product Status 66 Table 92: Mechanical Thrombectomy Device - Product Description 66 Table 93: Lazarus Effect, Inc Pipeline Products & Ongoing Clinical Trials Overview 67 Table 94: Lazarus Cover - Product Status 67 Table 95: Lazarus Cover - Product Description 67 Table 96: Lazarus Lynx - Product Status 68 Table 97: Lazarus Lynx - Product Description 68 Table 98: Lazarus ReCover - Product Status 69 Table 99: Lazarus ReCover - Product Description 69 Table 100: Medikit Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 70 Table 101: Aspirarecath - Product Status 71 Table 102: Aspirarecath - Product Description 71 Table 103: Axcelguide - Product Status 72 Table 104: Axcelguide - Product Description 72 Table 105: Cerulean G - Product Status 73 Table 106: Cerulean G - Product Description 73 Table 107: Slimguide - Product Status 74 Table 108: Slimguide - Product Description 74 Table 109: Merlin MD Pte. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 75 Table 110: Next Generation Device For Cerebral Aneurysm - Product Status 75 Table 111: Next Generation Device For Cerebral Aneurysm - Product Description 75 Table 112: X Calibur Aneurysm Occlusion Device - Product Status 76 Table 113: X Calibur Aneurysm Occlusion Device - Product Description 76 Table 114: Metactive Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 77 Table 115: Ballstent Microcatheter - Product Status 77 Table 116: Ballstent Microcatheter - Product Description 77 Table 117: MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 78 Table 118: Blood Clot Removing Device - Product Status 79 Table 119: Blood Clot Removing Device - Product Description 79 Table 120: Micro-Catheter - Product Status 80 Table 121: Micro-Catheter - Product Description 80 Table 122: Tubridge - Product Status 81 Table 123: Tubridge - Product Description 81 Table 124: MicroVention, Inc. Pipeline Products & Ongoing Clinical Trials Overview 82 Table 125: ERIC Clot Removal Device - Product Status 82


List of Figures
Figure 1: Interventional Neurology - Pipeline Products by Stage of Development 14 Figure 2: Interventional Neurology - Pipeline Products by Segment 15 Figure 3: Interventional Neurology - Pipeline Products by Territory 17 Figure 4: Interventional Neurology - Pipeline Products by Regulatory Path 18 Figure 5: Interventional Neurology - Pipeline Products by Estimated Approval Date 19 Figure 6: Interventional Neurology - Ongoing Clinical Trials 20

To request a sample copy of this report, please complete the form below.

Please Fill captcha Validation: tEOsZP
This website is secure and your personal details are safe. Privacy policy

Global compressed air treatment equipment market is projected to reach USD 8.59 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing implementation of this equipment in various industry sectors such as healthcare & pharmace

Read More...October 30, 2015

Global non destructive testing equipment market is anticipated to reach USD 5.76 billion by 2022, as per a new research report by Radiant Insights, Inc. Stringent government safety initiatives for inspection and quality control across numerous indust

Read More...October 21, 2015

Global activated carbon market size is likely to be valued at USD 5.3 billion by 2020; as per a new research report by Radiant Insights, Inc. Increase in commercial & residential waste water treatment demand owing to escalation in water prices is ant

Read More...October 30, 2015

Global animal feed additives market size was estimated at USD 16 billion in 2014. Growing meat consumption as a key protein source, especially in Asia Pacific and Latin America is expected to be a key driver for market demand over the forecast period

Read More...October 6, 2015

Global automotive coatings market size is likely to be valued at USD 27.7 billion by 2022; as per a new research report by Radiant Insights, Inc. Vehicle aesthetics, UV radiation and temperature variation protection and enhance durability are certain

Read More...October 29, 2015
Choose License Type
Single User - US$ 4000.00
Multi User - US$ 8000.00
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify